Abbott India's March quarter profit up y-o-y by 24%

10 May 2024 , 01:14 PM

Abbott India Ltd records a 24% year-on-year (YoY) growth in net profit, reaching ₹287 Crore for the fourth quarter of the financial year 2023-24.

The company’s revenue sees a 7% increase to ₹1,439 Crore from ₹1,343 Crore in the corresponding period of the previous year, as announced by Abbott India on May 9.

The board of Abbott India recommends a final dividend payment of ₹410 per equity share of ₹10 each for the fiscal year ended March 31, 2024, pending approval from shareholders. At the time of writing, Shares of Abbott India conclude trading 3.57% higher at ₹26,473 apiece on the NSE.

Abbott India, a subsidiary of Abbott Laboratories, is a leading player in pharmaceuticals, nutrition, devices, and diagnostics. Offering a portfolio of over 400 brands, it provides nutritional products catering to various age groups and special dietary needs, alongside medical devices and diagnostic solutions.

For feedback and suggestions, write to us at [e-mail]